Capricor Therapeutics, Inc. (CAPR) stock forecast and price target
Price $9.53 · data as of November 13, 2026
12-month price target
Average target$27.25
Upside / downside+185.9%
Analysts6
ConsensusBuy
Low $10.50Average $27.25High $54.00
Gold marker: average target · white marker: today’s price ($9.53)
Analyst ratings
Strong buy 1Buy 4Hold 5Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.45 | −8.5% | $13M |
| Next fiscal year ends December 31, 2027 | $-1.43 | +41.6% | $66M |
| Quarter after ends December 31, 2026 | $-0.44 | +28.6% | $11M |
Consensus of the analysts covering Capricor Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 7 lowered.
Frequently asked questions
What is the Capricor Therapeutics stock price target?
The average 12-month target from 6 analysts is $27.25, 185.9% above the current price of $9.53 Targets range from $10.50 to $54.00.
Is Capricor Therapeutics a buy according to analysts?
The consensus rating is “Buy” (1 strong buy, 4 buy, 5 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Capricor Therapeutics expected to earn?
Analysts expect EPS of $-2.45 for the fiscal year ending December 31, 2026 and $-1.43 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.